(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -85.22%32.01K | 220.66%99.64K | 869.16%146.93K | 869.16%146.93K | 902,585.00%180.54K | 7,395.67%216.63K | 5,002.13%31.07K | -62.59%15.16K | -62.59%15.16K | -99.98%20 |
-Cash and cash equivalents | -85.22%32.01K | 220.66%99.64K | 869.16%146.93K | 869.16%146.93K | 902,585.00%180.54K | 7,395.67%216.63K | 5,002.13%31.07K | -62.59%15.16K | -62.59%15.16K | -99.98%20 |
Receivables | -25.63%1.79K | 62.84%3.85K | 39.50%3.52K | 39.50%3.52K | -67.58%1.88K | 5.36%2.4K | -77.94%2.36K | -68.05%2.52K | -68.05%2.52K | 821.90%5.81K |
-Accounts receivable | -25.63%1.79K | 62.84%3.85K | 39.50%3.52K | 39.50%3.52K | -67.58%1.88K | 5.36%2.4K | -77.94%2.36K | -68.05%2.52K | -68.05%2.52K | 821.90%5.81K |
Prepaid assets | ---- | ---- | ---- | ---- | ---- | --0 | -25.68%1.18K | ---- | ---- | --0 |
Restricted cash | 5.35%107.12K | 5.44%105.8K | 5.06%104.38K | 5.06%104.38K | 4.60%102.98K | 3.88%101.69K | 2.76%100.34K | 1.87%99.35K | 1.87%99.35K | 1.08%98.46K |
Total current assets | -56.06%140.92K | 55.08%209.28K | 117.73%254.82K | 117.73%254.82K | 173.68%285.4K | 208.82%320.71K | 22.08%134.95K | -21.78%117.03K | -21.78%117.03K | -48.32%104.28K |
Non current assets | ||||||||||
Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --10.53K | --0 | --0 | --0 |
Total assets | -56.06%140.92K | 43.85%209.28K | 117.73%254.82K | 117.73%254.82K | 173.68%285.4K | 208.82%320.71K | 31.60%145.48K | -21.78%117.03K | -21.78%117.03K | -48.32%104.28K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current provisions | 0.00%42.02K | 0.00%42.02K | 0.00%42.02K | 0.00%42.02K | -43.18%42.02K | -43.18%42.02K | -43.18%42.02K | -43.18%42.02K | -43.18%42.02K | -8.56%73.94K |
Current liabilities | 1.25%66.05K | 14.21%100.35K | 6.79%88.98K | 6.79%88.98K | -65.86%65.7K | -53.54%65.24K | -10.44%87.86K | -12.52%83.33K | -12.52%83.33K | 77.28%192.45K |
Non current liabilities | ||||||||||
Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total liabilities | 1.25%66.05K | 14.21%100.35K | 6.79%88.98K | 6.79%88.98K | -65.86%65.7K | -53.54%65.24K | -10.44%87.86K | -12.52%83.33K | -12.52%83.33K | 77.28%192.45K |
Shareholders'equity | ||||||||||
Share capital | 0.00%22.46M | 1.11%22.46M | 1.65%22.46M | 1.65%22.46M | 2.82%22.46M | 2.82%22.46M | 1.69%22.21M | 1.15%22.09M | 1.15%22.09M | 0.00%21.84M |
-common stock | 0.00%22.46M | 1.11%22.46M | 1.65%22.46M | 1.65%22.46M | 2.82%22.46M | 2.82%22.46M | 1.69%22.21M | 1.15%22.09M | 1.15%22.09M | 0.00%21.84M |
Retained earnings | -1.34%-23.85M | -1.84%-23.7M | -1.78%-23.64M | -1.78%-23.64M | -1.53%-23.57M | -2.66%-23.53M | -1.75%-23.27M | -1.75%-23.23M | -1.75%-23.23M | -1.84%-23.21M |
Gains losses not affecting retained earnings | 10.22%1.46M | 20.64%1.35M | 15.55%1.35M | 15.55%1.35M | 3.65%1.33M | 27.28%1.33M | 7.33%1.12M | 12.07%1.17M | 12.07%1.17M | 22.79%1.28M |
Total stockholders'equity | -70.70%74.86K | 89.07%108.94K | 391.97%165.84K | 391.97%165.84K | 349.19%219.71K | 798.76%255.47K | 363.14%57.62K | -38.01%33.71K | -38.01%33.71K | -194.56%-88.17K |
Total equity | -70.70%74.86K | 89.07%108.94K | 391.97%165.84K | 391.97%165.84K | 349.19%219.71K | 798.76%255.47K | 363.14%57.62K | -38.01%33.71K | -38.01%33.71K | -194.56%-88.17K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data